156 related articles for article (PubMed ID: 22196127)
1. Expression of therapeutic targets in Ewing sarcoma family tumors.
Ahmed AA; Sherman AK; Pawel BR
Hum Pathol; 2012 Jul; 43(7):1077-83. PubMed ID: 22196127
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
Ahmed A; Gilbert-Barness E; Lacson A
Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
[TBL] [Abstract][Full Text] [Related]
5. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
6. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
Quesada AE; Nguyen ND; Rios A; Brown RE
Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity.
Singhal E; Sen P
Int J Biochem Cell Biol; 2011 Aug; 43(8):1134-46. PubMed ID: 21536148
[TBL] [Abstract][Full Text] [Related]
8. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
[TBL] [Abstract][Full Text] [Related]
11. Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.
Aryee DN; Ambros I; Ambros PF; Muehlbacher K; Luegmayr A; Yoshie O; Kovar H
Pediatr Res; 2002 Aug; 52(2):279-85. PubMed ID: 12149507
[TBL] [Abstract][Full Text] [Related]
12. Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome.
Mora J; Rodríguez E; de Torres C; Cardesa T; Ríos J; Hernández T; Cardesa A; de Alava E
Pediatr Blood Cancer; 2012 Apr; 58(4):532-8. PubMed ID: 21994054
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
Lee JA; Kim DH; Lim JS; Koh JS; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
Jpn J Clin Oncol; 2010 Nov; 40(11):1060-7. PubMed ID: 20513751
[TBL] [Abstract][Full Text] [Related]
15. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
16. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.
Wu MH; Lo JF; Kuo CH; Lin JA; Lin YM; Chen LM; Tsai FJ; Tsai CH; Huang CY; Tang CH
J Cell Physiol; 2012 Aug; 227(8):3016-26. PubMed ID: 21959927
[TBL] [Abstract][Full Text] [Related]
18. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.
Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS
Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
20. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]